Phio Pharmaceuticals Corp. (PHIO) AI Dilution Summary

PHIO is funding itself against cash of $12,996,000 at 2026-06-30 and estimated monthly burn of $1,339,667. Its funding channel is an active at-the-market program with H.C. Wainwright & Co., LLC, authorised to $6,360,000, with $0 sold to date. Dilution here is driven primarily by that $6,360,000 ATM program, which is sized in dollars rather than shares.